McPhail, Abby
Hare, Marion E.
Talcott, G. Wayne
Little, Melissa A.
Bursac, Zoran
Krukowski, Rebecca A.
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK104872)
Article History
Accepted: 22 May 2023
First Online: 8 June 2023
Declarations
:
: The authors declare no conflict of interest. The research represents a Collaborative Research and Development Agreement with the United States Air Force (CRADA #18-282-59MDW-C19002). The opinions expressed in this document are solely those of the authors and do not represent an endorsement by or the views of the United States Air Force, the Department of Defense, or the United States Government. The views expressed are those of the authors and do not reflect the official views or policy of the Department of Defense or its Components.The voluntary, fully informed consent of the subjects used in this research was obtained as required by 32 CFR 219 and DODI 3216.02_AFI 40–402.
: The trial is registered on clinicaltrials.gov (NCT 03057808). The protocol was approved by the Institutional Review Board (IRB) of the 59th Medical Wing and acknowledged by the University of Tennessee Health Science Center IRB. A detailed description of this study’s methods and rationale has been published (Fahey et al.,). The study was approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Free to read: This content has been made available to all.